ERBB2 and central nervous system cancer: Besides, miR‐1236 could decrease HER2 expression levels in glioma cells, while inhibiting miR‐1236 with locked nucleic acid (LNA) enhanced HER2 expressions (Figure 5D), indicating that miR‐1236 could regulate HER2 expression in glioma.